Osteopontin: role in cell signaling and cancer progression.

By Hema Rangaswami, Anuradha Bulbule, G. Kundu. Trends in Cell Biology, 2006

745 citations recorded by the source corpus.

Subfields: Molecular Biology, Oncology, Rheumatology

View Paper: https://www.semanticscholar.org/paper/64c3f44c5aa8501ee4275c135eb921511e4cf58d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. P. Vaupel
2. D. Scadden
3. A. Mayer

In Oncology

1. A. Mayer
2. P. Vaupel
3. D. Scadden

Citations in the corpus

• CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis. (2014, background): “OPN is a cytokine produced by fibroblasts and immune and endothelial cells that is involved in several biological processes during bone turnover, tumorigenesis (Rangaswami et al., 2006), inflammation, and immune response (Cantor and Shinohara, 2009).”
• The stem-cell niche as an entity of action (2006, background): “Implicated previously in tumour metastasis and cell-mediated immunit”
• Hypoxia in cancer: significance and impact on clinical outcome (2007, background): “Overexpression of osteopontin (OPN) has been demonstrated to be involved in metastasis formation [93] by virtue of its integrin and CD44 binding sites.”